GNLX - Genelux Corporation Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
5.28 0.17 (3.22%)	---	---	---	---	0.17 (3.22%)	---	---

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.2
Diluted EPS:: -0.2
Basic P/E:: -27.25
Diluted P/E:: -27.25
RSI(14) 1m:: 87.5
VWAP:: 5.43
RVol:: 1.4864

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	5.37 +0.07 (+1.23%)	Oct 15 14:40
1m	Price decrease 1m	5.21 -0.07 (-1.33%)	Oct 15 13:28
1m	Price decrease 1m	5.3 -0.11 (-2.02%)	Oct 15 12:28
1m	Price increase 1m	5.41 +0.06 (+1.12%)	Oct 15 10:26
1m	Price increase 1m	5.53 +0.09 (+1.65%)	Oct 15 09:57